ba ƙaramin maganin ciwon huhu ba

Maganin ciwon huhu mara ƙanƙanta Zaɓuɓɓukan (NSCLC) sun bambanta kuma sun dogara da mataki, nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i nau'i). Jiyya na yau da kullun sun haɗa da tiyata, maganin radiation, chemotherapy, farfesa da aka yi niyya, da immunotherapy, galibi ana amfani da su a hade. Wannan jagorar yana bincika kowane zaɓi daki-daki, yana taimaka muku fahimtar yuwuwar da kuma yanke shawara mai fa'ida tare da tuntuɓar ƙungiyar kula da lafiyar ku.Fahimtar Ciwon Kanji mara Ƙaramar Kwayoyin Halitta (NSCLC) Menene NSCLC?Ciwon daji na huhu mara ƙarami (NSCLC) shine nau'in ciwon huhu da aka fi sani da shi, wanda ke lissafin kusan kashi 80-85% na duk cutar kansar huhu. It's an umbrella term that includes several subtypes, the most common being adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.NSCLC StagingThe stage of NSCLC is crucial for determining the best treatment approach. An ƙayyade matakin ta girman girman da wurin da ƙwayar cuta ta kasance, ko ya yada zuwa nodes na lymph na kusa, da kuma ko ya daidaita zuwa gabobin da ke da nisa.Zaɓuɓɓukan jiyya don NSCLCSurgerySurgery sau da yawa shine jiyya na farko don matakin farko na NSCLC. Manufar ita ce a cire ciwace-ciwacen daji da duk wani nau'in lymph na kusa wanda zai iya ƙunshi ƙwayoyin kansa. Lobectomy: Cire gaba ɗaya lobe na huhu. Pneumonectomy: Cire dukkan huhu. Tsawon tsinke: Cire ƙaramin yanki na huhu mai siffa mai siffa. Segmentectomy: Cire wani yanki na huhu, wanda ya fi girma fiye da raguwa amma karami fiye da lobectomy.Lura: Tiyata bazai zama zaɓi ga marasa lafiya da ke da ci-gaba NSCLC ko waɗanda ke da wasu yanayin kiwon lafiya waɗanda ke sa tiyata ta yi haɗari sosai.Radiation TherapyRadiation far yana amfani da haskoki masu ƙarfi don kashe ƙwayoyin cutar kansa. Ana iya amfani da shi don magance NSCLC ta hanyoyi da yawa: External Beam Radiation Therapy (EBRT): Ana isar da radiation daga na'ura a wajen jiki. Stereotactic Jikin Radiation Therapy (SBRT): Madaidaicin nau'i na EBRT wanda ke ba da babban adadin radiation zuwa ƙaramin yanki. Yawancin lokaci ana amfani da shi don ciwon huhu na farko lokacin da tiyata ba ta yiwuwa. Brachytherapy: Ana sanya kayan aikin rediyo kai tsaye a cikin ko kusa da ƙari. Za a iya amfani da maganin radiation shi kaɗai ko a hade tare da wasu jiyya, kamar chemotherapy. Mu a Shandong Baofa Cibiyar Nazarin Ciwon daji fahimci mahimmancin haɗa magunguna don sakamako mafi kyau. Baofa jagora ne a cikin hadaddiyar kulawar ciwon daji.ChemotherapyChemotherapy yana amfani da kwayoyi don kashe ƙwayoyin kansa a cikin jiki. Ana amfani da shi sau da yawa don kula da ci gaba na NSCLC ko don hana ciwon daji daga sake dawowa bayan tiyata. Magungunan chemotherapy na yau da kullun na NSCLC sun haɗa da: Cisplatin Carboplatin Pemetrexed Docetaxel PaclitaxelChemotherapy yawanci ana ba da shi a cikin hawan keke, tare da lokutan jiyya na biye da lokutan hutu. Hanyoyin illa na iya bambanta dangane da magungunan da aka yi amfani da su da kuma majinyacin mutum.Targeted TherapyTargeted therapy yana amfani da kwayoyi waɗanda ke da takamaiman ƙwayoyin cuta da ke da hannu a ci gaban kwayar cutar kansa da rayuwa. Waɗannan magungunan galibi sun fi tasiri kuma suna da ƙarancin illa fiye da chemotherapy. Magungunan da aka yi niyya yawanci ga marasa lafiya tare da takamaiman maye gurbi. Makasudin gama gari sun haɗa da: EGFR: Epidermal Growth Factor Recetor ALK: Anaplastic Lymphoma Kinase ROS1: ROS1 Mai karɓar Proto-Oncogene Tyrosine Kinase BRAF: B-Raf Proto-Oncogene, Serine/Treonine Kinase NTRK: Neurotrophic Tyrosine Receptor KinaseMisalan magungunan da aka yi niyya da aka yi amfani da su don NSCLC sun haɗa da: Gefitinib (Iressa) Erlotinib (Tarceva) Afatinib (Gilotrif) Osimertinib (Tagrisso) Crizotinib (Xalkori) Ceritinib (Zykadia) Alectinib (Alecensa) da aka yi niyya ga marasa lafiya da aka yi niyya idan aka yi niyya idan an gwada su Before maye gurbi.ImmunotherapyImmunotherapy yana amfani da kwayoyi don taimakawa tsarin garkuwar jiki yaƙar kansa. Wadannan kwayoyi zasu iya toshe sunadaran da ke hana tsarin rigakafi daga kai hari ga kwayoyin cutar kansa. Magungunan rigakafi na yau da kullun don NSCLC sun haɗa da: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Atezolizumab (Tecentriq) Durvalumab (Imfinzi) Immunotherapy ana iya amfani da shi kaɗai ko a hade tare da chemotherapy ko wasu jiyya. Side effects iya hada da gajiya, fata rashes, da kumburi na daban-daban gabobin.NSCLC Jiyya ta StageStage I NSCLCSurgery ne sau da yawa jiyya na farko ga Stage I NSCLC. Ana iya la'akari da SBRT idan majiyyaci ba ɗan takarar tiyata bane.Stage II NSCLCTreatment for Stage II NSCLC yawanci ya haɗa da tiyata tare da chemotherapy. Hakanan za'a iya amfani da maganin radiation.Stage III NSCLCT Magani don Stage III NSCLC ya fi rikitarwa kuma yana iya haɗawa da haɗin tiyata, chemotherapy, da radiation far. Hakanan za'a iya amfani da maganin rigakafi bayan chemoradiation a wasu lokuta.Stage IV NSCLCT magani ga Stage IV NSCLC yana mai da hankali kan sarrafa ci gaban ciwon daji da kuma kawar da alamun bayyanar cututtuka. Zaɓuɓɓukan na iya haɗawa da chemotherapy, maganin da aka yi niyya, immunotherapy, da maganin radiation. Zaɓin jiyya ya dogara da takamaiman halaye na ciwon daji da kuma lafiyar majiyyaci gabaɗaya.Gwajin na asibiti Gwajin asibiti binciken bincike ne da ke gwada sabbin hanyoyin magance cutar kansa. Marasa lafiya tare da NSCLC na iya cancanci shiga cikin gwaji na asibiti. Yi magana da likitan ku don ƙarin koyo game da gwaji na asibiti da ko sun dace da ku. Shandong Baofa Cibiyar Nazarin Ciwon daji sadaukar da kai ga bincike yana nufin mu tsaya a ƙarshen sabbin zaɓuɓɓukan jiyya, wani lokacin ta hanyar gwaji na asibiti.Yin Shawarar Jiyya Zaɓin jiyya mai kyau ga NSCLC shine yanke shawara mai rikitarwa wanda yakamata a yi tare da shawarwarin ƙungiyar kula da lafiyar ku. Abubuwan da za a yi la'akari sun haɗa da mataki da nau'in ciwon daji, gabaɗayan lafiyar majiyyaci, da abubuwan da suke so. Kada ku yi jinkirin yin tambayoyi kuma ku nemi ra'ayi na biyu idan an buƙata. Hasashen Hasashen da Rayuwar Rayuwa Yawan Rayuwa na NSCLC ya bambanta dangane da matakin ciwon daji, maganin da aka karɓa, da sauran dalilai. Ganowa da wuri da magani na iya inganta damar rayuwa. Matsayin Rayuwa na Shekaru 5 Matsayin Matsayi na 68-92% Mataki na II 53-60% Mataki na III 13-36% Mataki na IV Kasa da 10% *Madogararsa: Ƙungiyar Ciwon daji ta Amurka (www.cancer.orgRayuwa tare da NSCLCLiving tare da NSCLC na iya zama ƙalubale, amma akwai albarkatu da yawa da ke akwai don taimakawa marasa lafiya da danginsu su jimre. Waɗannan albarkatun sun haɗa da ƙungiyoyin tallafi, sabis na ba da shawara, da shirye-shiryen taimakon kuɗi.